Rethinking the concept of disease modification in an evolving Parkinson's disease treatment landscape

Journal of Parkinson’s Disease · Published 2026-09-15 · Journal article · DOI 10.1177/1877718x261481704

Free full text

Authors (11)

Angelo Antonini, Robert E Gross, Maria De Leon, Kevin Kwok, Tom Foltynie, Günter Höglinger, Thomas Gasser, Jean-Christophe Corvol, David J. Pedrosa, Jens Volkmann, Claire Henchcliffe

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Antonini, A., Gross, R., Leon, M., et al. (2026). Rethinking the concept of disease modification in an evolving Parkinson's disease treatment landscape. Journal of Parkinson’s Disease. https://doi.org/10.1177/1877718x261481704

Related articles

• Integrating a biopsychosocial perspective: WHODAS 2.0 enhances functioning assessment in Parkinson's disease · Journal of Parkinson’s Disease · 2026 · Same journal
• A case of monotherapy with intracerebroventricular anaerobic dopamine allows complete control of Parkinson's disease symptoms · Journal of Parkinson’s Disease · 2025 · Same journal
• A review of FDG-PET biomarker analysis methods in Parkinson's disease · Journal of Parkinson’s Disease · 2026 · Same journal
• Effects of deep brain stimulation on functional autonomy and quality of life in Parkinson's disease: A systematic review and meta-analysis · Journal of Parkinson’s Disease · 2026 · Same journal
• Association between age at Parkinson's disease onset and divorce: An exploratory analysis from the fox insight cohort · Journal of Parkinson’s Disease · 2026 · Same journal
• Continuous apomorphine infusion modulates cortical hyperexcitability and abnormal plasticity in Parkinson's disease · Journal of Parkinson’s Disease · 2026 · Same journal
• Cognition endpoints for Parkinson's disease: A roadmap for developing patient-focused assessment tools to accelerate drug development · Journal of Parkinson’s Disease · 2026 · Same journal
• Gut microbiome dysbiosis, short-chain fatty acid depletion and implications for neuroinflammation in atypical parkinsonian syndromes – a systematic review of patient cohorts · Journal of Parkinson’s Disease · 2026 · Same journal
• Aligning incentives for open science in biomedical research: Navigating funder and institutional perspectives · Journal of Parkinson’s Disease · 2025 · Same journal
• Prevalence and related factors of blood pressure regulation abnormalities in Parkinson's disease: Orthostatic hypotension and supine hypertension · Journal of Parkinson’s Disease · 2025 · Same journal